Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis.
Journal: Therapeutic advances in gastroenterology
Published: January 28, 2021
Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis.
Journal: Drug safety
Published: October 07, 2020
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: April 28, 2020
Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies.
Journal: Inflammatory bowel diseases
Published: April 01, 2020
Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open.
Journal: Alimentary pharmacology & therapeutics
Published: June 28, 2019
The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis.
Journal: Journal of Crohn's & colitis
Published: March 18, 2019
Long-term safety and tolerability of oral tofacitinib in patients with Crohn's disease: results from a phase 2, open-label, 48-week extension study.
Journal: Alimentary pharmacology & therapeutics
Published: April 24, 2018
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.
Journal: Gut
Published: July 27, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026